Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Myeloperoxidase antibody

The Mouse Monoclonal anti-Myeloperoxidase antibody has been validated for WB, FACS, IHC (p), IHC (fro) and EIA. It is suitable to detect Myeloperoxidase in samples from Human. There are 2+ publications available.
Catalog No. ABIN119048

Quick Overview for Myeloperoxidase antibody (ABIN119048)

Target

See all Myeloperoxidase (MPO) Antibodies
Myeloperoxidase (MPO)

Reactivity

  • 175
  • 62
  • 55
  • 8
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 135
  • 84
  • 1
  • 1
  • 1
Mouse

Clonality

  • 124
  • 98
Monoclonal

Conjugate

  • 106
  • 30
  • 26
  • 11
  • 9
  • 9
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Myeloperoxidase antibody is un-conjugated

Application

  • 127
  • 84
  • 74
  • 61
  • 41
  • 38
  • 33
  • 17
  • 14
  • 14
  • 14
  • 12
  • 10
  • 7
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)

Clone

2C7
  • Purification

    Affinity Chromatography on Protein G

    Immunogen

    Human Myeloperoxidase. Spleen cells from immunised mice were fused with cells of the mouse X63 AG8653 myeloma cell line.

    Isotype

    IgG1
  • Application Notes

    Flow Cytometry (1/50-1/100): Membrane permeabilisation is required. The antibody may be of value in the study of myeloid cells and myeloid leukaemias by flow cytometry. Immunhistology on Frozen Sections (1/1000-1/5000). Immunhistology on Paraffin Sections (1/500-1/1000): use bone marrow as positive control. ELISA. Western blotting (Non reducing conditions): ABIN119048 recognises native MPO in Western blots, and the heavy chain following boiling of the sample. The antibody also recognises recombinant MPO in Western blots and weakly in ELISA.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS containing 0.09 % Sodium Azide as preservative

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • OBrien, Abdulahad, Rutgers, Huitema, OReilly, Coughlan, Harrington, Heeringa, Little, Hickey: "Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies." in: Scientific reports, Vol. 5, pp. 11888, (2015) (PubMed).

    Schreiber, Xiao, Jennette, Schneider, Luft, Kettritz: "C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis." in: Journal of the American Society of Nephrology : JASN, Vol. 20, Issue 2, pp. 289-98, (2009) (PubMed).

  • Target

    Myeloperoxidase (MPO)

    Alternative Name

    Myeloperoxidase

    Background

    Myeloperoxidase/MPO is an important component of azurophilic granules in neutrophils, being involved in microbicidal processes. The protein is a multimer of 2 heavy chains (55 kD) and two light chains (15 kD), the heavy chains being linked by a disulphide bond. Myeloperoxidase is a hemoprotein that is abundantly expressed in neutrophils and secreted during their activation. Native Myeloperoxidase is represented as a covalently bound tetrameric complex of two glycosylated alpha chains (MW 59-64 kDa) and two unglycosylated beta chains (MW 14 kDa) with total MW 150 kDa and theoretical pI 9.2. Traditionally Myeloperoxidase was considered as a main target of anti-neutrophil cytoplasm antibodies (ANCA), the serological markers for certain systemic vasculities e.g. periarteriitis nodosa, microscopic polyarteriitis and pulmonary eosinophilic granulomatosis (Churg-Strauss syndrome). Low to moderate anti-Myeloperoxidase auto-antibody levels are also reported in rheumatoid arthritis. Recently it was shown that Myeloperoxidase participates in the initiation and progression of cardiovascular disease. It possesses potent proinflammatory properties and may contribute directly to tissue injury. Now Myeloperoxidase is under consideration as one of the most promising cardiac markers.Synonyms: MPO

    Gene ID

    9606

    UniProt

    P05164

    Pathways

    Chromatin Binding
You are here:
Chat with us!